Recipharm names 2018 International Environmental Award winner

Recipharm has announced that its 2018 International Environmental Award will be presented to Dr. Bryan Brooks, Distinguished Professor in Environmental Science and Biomedical Studies at Baylor University in Waco, Texas.

Dr. Brooks' transdisciplinary research includes understanding and managing human activities and environmental stressors across levels of biological organization, particularly in rapidly urbanizing regions. His current research with students focuses on water quality and water reuse, comparative toxicology and pharmacology, sustainable molecular design, environmental public health, and the ecology and toxicology of harmful algal blooms.

His research also contributes to developing science-based approaches to identify, diagnose and manage complex environment and health issues.

Lars Backsell, Chairman of the board of Recipharm said: “We are delighted to present the 2018 award to Bryan Brooks. His work, which explores the potential effects and risks of contaminants, including pharmaceuticals, on the environment is widely recognised in our industry and beyond. This research will help to build a greater understanding of the impact of certain contaminants on the environment and could potentially provide invaluable guidance on how to reduce any negative effects.”

Dr. Brooks routinely works internationally on water quality, environmental contaminants and sustainability issues and is a frequent presenter at international meetings. In 2012, Dr. Brooks published (with Dr. Duane Huggett) Human Pharmaceuticals in the Environment: Current and Future Perspectives.

His research efforts are supported by the National Institutes of Health, the National Science Foundation, Centers for Disease Control and Prevention, the U.S. Department of Agriculture, the U.S. Environmental Protection Agency, as well as local government and businesses.

Dr. Brooks, who also coordinates the strategic Global Horizon Scanning Project, which aims to identify priority research questions that will help to achieve sustainable environmental quality around the world, said: “I am humbled and honored to receive this award from Recipharm, which I warmly accept on behalf of our current and former students. I am grateful for support from Baylor University, my long time collaborators Prof. Kevin Chambliss and Dr. Duane Huggett, and other close colleagues with whom we are engaging research on six continents."

“More and more people are living in urban areas, which has contamination implications for water and food, and as a result generates some complex health risks. However, it also presents a number of opportunities to reduce waste and exposures, to increase resource recovery, and to design less hazardous chemicals for the protection of public health and the environment."

“Our research examines interfaces among environment and health with a goal of understanding and managing challenges that affect us all, so we’re delighted to be acknowledged for our team’s contributions.”

Dr. Brooks will be awarded the Recipharm International Environment Award at a prize ceremony in Stockholm June 3rd, 2019. The programme and speakers will be announced later this spring. 

Contact information
Lars Backsell, Recipharm Chairman of the Board, +46 8 602 52 00
Erik Haeffler, Vice President Manufacturing Services & Head of Sustainability, erik.haeffler@recipharm.com+ 46 8 6025 285 

For media enquiries, please contact Kate Hindhaugh at ramarketing: kate@ramarketingpr.com, + 44 (0)191 222 1242, ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr, Linkedin: /ramarketing 
For media enquiries Baylor University, please contact Tonya B. Hudson, Director, Media and Public Relations, +1-(254) 710-4656, Tonya_Hudson@baylor.edu 

About Recipharm
Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing around 6,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm’s turnover is approximately SEK 6.4 billion and the company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.

For more information on Recipharm and our services, please visit www.recipharm.com

 

About Recipharm’s International Environmental Award             
Since Recipharm was founded in 1995, our environmental agenda has been a central part of the way we do business. It is our belief that transparency, cooperation and encouragement are necessary if we are to achieve sustainable development. In order to promote this belief, we introduced an international environmental award in 2008 for the best environmental practice or innovation within the pharmacy and health care industries or academia.

For more information visit https://www.recipharm.com/sustainability/recipharm-international-environmental-award

Recipharm AB (publ), Org. nr 556498-8425
Adress Box 603, 101 32 Stockholm, Sverige, Telefon 46 8 602 52 00
www.recipharm.com

Tags:

About Us

About RecipharmRecipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry employing some 6,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from Big Pharma to smaller research- and development companies. Recipharm’s turnover is approximately SEK 6.4 billion and the company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm. For more information on Recipharm and our services, please visit www.recipharm.com

Subscribe

Quotes

We are delighted to present the 2018 award to Bryan Brooks. His work, which explores the potential effects and risks of contaminants, including pharmaceuticals, on the environment is widely recognised in our industry and beyond. This research will help to build a greater understanding of the impact of certain contaminants on the environment and could potentially provide invaluable guidance on how to reduce any negative effects.
Lars Backsell, Chairman of the board of Recipharm
I am humbled and honored to receive this award from Recipharm, which I warmly accept on behalf of our current and former students. I am grateful for support from Baylor University, my long time collaborators Prof. Kevin Chambliss and Dr. Duane Huggett, and other close colleagues with whom we are engaging research on six continents. /.../ Our research examines interfaces among environment and health with a goal of understanding and managing challenges that affect us all, so we’re delighted to be acknowledged for our team’s contributions.
Dr. Bryan Brooks